Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd
Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd
favorite supplier
Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd
Established in November 2020, Nano Diagnosis for Health Biotech (Guangzhou) Co., Ltd. (abbreviated as CNDH), has been jointly incubated by The GBA National Institute for Nanotechnology Innovation and National Engineering Research Center for Nanomedicine.
CNDH is a professional biotech enterprise focusing on the research, development, production and sales of rapid detection reagents and equipment relating to drugs of abuse and animal diseases. Main products include DOA rapid test kits for urine/ saliva/ hair specimens, handheld drug analyzers, and animal disease rapid test kits.
CNDH has self-owned over 3000m2 of R&D, production and office space in Huangpu District, Guangzhou City, and has equipped with internationally advanced R&D and production facilities. The company is dedicated to apply our leading nanotechnology with the platforms of immune colloidal gold technology, immunofluorescence technology, and molecular diagnostic technology to rapid detection.
The strong scientific research background and the international leading nanotechnology are the natural advantages of CNDH. CNDH is led by Academicians of the Chinese Academy of Sciences with a professional R&D team of Nanobiology and Nanomedicine doctors and masters. This R&D team, which accounts for more than 70% of the company's employees, has been the wellspring of dozens of nanotechnology achievements and patents for the company.
+
More
CNDH is a professional biotech enterprise focusing on the research, development, production and sales of rapid detection reagents and equipment relating to drugs of abuse and animal diseases. Main products include DOA rapid test kits for urine/ saliva/ hair specimens, handheld drug analyzers, and animal disease rapid test kits.
CNDH has self-owned over 3000m2 of R&D, production and office space in Huangpu District, Guangzhou City, and has equipped with internationally advanced R&D and production facilities. The company is dedicated to apply our leading nanotechnology with the platforms of immune colloidal gold technology, immunofluorescence technology, and molecular diagnostic technology to rapid detection.
The strong scientific research background and the international leading nanotechnology are the natural advantages of CNDH. CNDH is led by Academicians of the Chinese Academy of Sciences with a professional R&D team of Nanobiology and Nanomedicine doctors and masters. This R&D team, which accounts for more than 70% of the company's employees, has been the wellspring of dozens of nanotechnology achievements and patents for the company.
leave a message
- phone : view details
- address : 7-8F D Bldg. No.136 Kaiyuan Avenue, Huangpu District, Guangzhou, Guangdong, 510535 P.R.China
- postcode : 510535
- website : http://en.cndhbio.com/